Concepedia

Patients with Obesity Caused by Melanocortin-4 Receptor Mutations Can Be Treated with a Glucagon-like Peptide-1 Receptor Agonist

Eva W. Iepsen, Jinyi Zhang, Henrik S. Thomsen, Elizaveta L. Hansen, Mette Hollensted, Sten Madsbad, Torben Hansen, Jens J. Holst, Jens‐Christian Holm, Signe S. Torekov

Cell Metabolism · 2018 · 149 citations · 49 references

DOIFull text

Open access

Concepts

References

49

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

Steven P. Marso, Gilbert H. Daniels, Kirstine Brown‐Frandsen et al. · New England Journal of Medicine · 2016 · 7.3K citations · Full text

, , +13

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

Masafumi Matsuda, Ralph A. DeFronzo · Diabetes Care · 1999 · 5.6K citations

, , +12

Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies

The Lancet · 2009 · 4.8K citations · Full text

, , +13

Targeted Disruption of the Melanocortin-4 Receptor Results in Obesity in Mice

Dennis Huszar, Catherine Lynch, Victoria Fairchild-Huntress et al. · Cell · 1997 · 3K citations · Full text

, , +11

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management

F. Xavier Pi‐Sunyer, Arne Astrup, Ken Fujioka et al. · New England Journal of Medicine · 2015 · 2.6K citations · Full text

, , +17